1.Clinical Consideration of Prednisolone Induced Cataract.
Journal of the Korean Ophthalmological Society 2004;45(5):732-735
PURPOSE: The purpose of this paper was to examine the correlation between the development of posterior subcapsular cataract and the dosage and duration of systemic steroid therapy. METHODS: Twenty-two eyes which underwent cataract surgery at our ophthalmologic department were enrolled, along with 20 randomly selected eyes, which received prednisolone therapy at least for 1 year. We examined prednisolone dosage, duration and systemic disorders. We compare daily prednisolone dosage, and duration between the subcapsular opacity group and the non-subcapsular opacity group. SPSS, with 2 way- ANOVA system, was used for statistical analysis. RESULTS: The development of posterior subcapsular cataract was correlated with the daily prednisolone dosage, but not with the duration of prednisolone therapy (p<0.05). CONCLUSIONS: Careful attention to the daily steroid dosage is required to prevent posterior subcapsular cataract formation.
Cataract*
;
Prednisolone*
2.The clinical effects of prednisolone withdrawal followed by recombinant alpha-interferon 2b therpy in the patients with CAH type B.
Chong Sun LEE ; Byung Ho KIM ; Ja Won SUNG ; Sung Sik HUR ; Ki Cheon LEE ; Hyun Yong JEONG ; Heon Young LEE ; Young Kun KIM
Korean Journal of Medicine 1993;45(5):588-596
No abstract available.
Humans
;
Interferon-alpha*
;
Prednisolone*
3.The effect of prednisolone on serum theophylline concentration in Korean pediatric patients with asthma.
Hyea Kyeong CHUNG ; Hee Jung LEE ; Un Ki YOUN ; Ji Sub OH
Pediatric Allergy and Respiratory Disease 1993;3(1):50-58
No abstract available.
Asthma*
;
Humans
;
Prednisolone*
;
Theophylline*
4.Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab.
Ji Young MOON ; Deog Yeon JO ; So Yeon LEE ; Deok Yeong KIM ; Seung Woo BAEK ; Ik Chan SONG
Blood Research 2017;52(4):337-339
No abstract available.
Hemoglobinuria, Paroxysmal*
;
Humans
;
Prednisolone*
6.Psoriasiform Sarcoidosis.
Seung Eun CHANG ; Kee Chan MOON ; Jai Kyoung KOH
Korean Journal of Dermatology 1998;36(5):965-966
We repart herein a case of psoriasifomi sarcoidosis. A histopathological examination reveaied sarcoidal ulomas throughout the dermis. There wa no systemic nvolvement, The skin lesions resolved aftier one month following treatment with low dose oral prednisolone. This is the first case of psoriasiform sarcoidosis in Korea.
Dermis
;
Korea
;
Prednisolone
;
Sarcoidosis*
;
Skin
7.Resistant Pityriasis Lichenoides et Varioloformis Acuta: Successful Treatment with Prednisolone and Methotrexate.
Young HER ; Chul Woo KIM ; Sang Seok KIM
Korean Journal of Dermatology 2015;53(7):563-564
No abstract available.
Methotrexate*
;
Pityriasis Lichenoides*
;
Pityriasis*
;
Prednisolone*
8.Interstitial lung disease associated with polymyositis:response to cyclophosphamide and prednisolone combination treatment.
Jong Ho MOON ; Jun Young PARK ; Sang Moo LEE ; Hyeon Tae KIM ; Soo Taek UH ; Yeon Tae CHUNG ; Yong Hoon KIM ; Choon Sik PARK ; Kyung Soo LEE
Tuberculosis and Respiratory Diseases 1993;40(2):197-202
No abstract available.
Cyclophosphamide*
;
Lung Diseases, Interstitial*
;
Prednisolone*
9.Comparison of Ketoconazole-Prednisolone Combination Therapy with Prednisolone Alone in Patients with Hormone Refractory Prostate Cancer.
Bong Kee CHOI ; Choal Hee PARK ; Chun Il KIM
Korean Journal of Urology 2000;41(10):1183-1189
No abstract available.
Humans
;
Prednisolone*
;
Prostate*
;
Prostatic Neoplasms*
10.Clinical Effects of Combined Treatment of Prednisolone and Psoralen on Vitiligo.
Yang Ja PARK ; Soon Bok LEE ; Dong Gil BYUN
Korean Journal of Dermatology 1974;12(2):21-24
Although the psoralen therapy has been used extensively on vitligo since the : introduction by El-Mofty on 1948, the result has not been satisfactory. Recent investigations showed that the autoimmune mechanism might be the causative factor to the development of vitiligo, and the use of steroid might be expected to be beneficial in the treatment of this disorder. Authors tried the combined treatment of prednisolone and psoralen on vitiligo and the results obtained are as follows; 1. Repigmentations began to develop from injected area of prednisolone as well as frorn hair follicles and peripheral area of the lesions. 2. More satisiactory responses were obtained on the widespread and symmetrical lesions of shorter duration than on the lesions of localized and long duration.
Ficusin*
;
Hair Follicle
;
Prednisolone*
;
Vitiligo*